Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo)

We studied whether addition of enfuvirtide (ENF) to a background combination antiretroviral therapy (cART) would improve the CD4 cell count response at week 24 in naive patients with advanced HIV disease. ANRS 130 Apollo is a randomized study, conducted in naive HIV-1-infected patients, either asymp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Joly, Véronique, Fagard, Catherine, Grondin, Carine, Descamps, Diane, Yazdanpanah, Yazdan, Charpentier, Charlotte, Colin de Verdiere, Nathalie, Tabuteau, Sophie, Raffi, François, Cabie, André, Chene, Geneviève, Yeni, Patrick
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2013
Aiheet:
Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553717/
https://ncbi.nlm.nih.gov/pubmed/23165467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01662-12
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia